Patents by Inventor Friedrich Luft

Friedrich Luft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides of the ATreceptor and their uses
    Patent number: 7745139
    Abstract: Disclosed are peptides of the AT1 receptor and their use for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension. The peptides may, for example, be used for the diagnosis of preeclampsia. Peptides having the sequence AFHYESQ (SEQ ID NO: 1), AVHYQSN (SEQ ID NO: 2), SHFYQTR (SEQ ID NO: 3), GYYFDTN (SEQ ID NO: 4) or ENTNIT (SEQ ID NO: 5) are preferred.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: June 29, 2010
    Assignee: Max-Delbrück-Centrum für Molekulare Medizin
    Inventors: Gerd Wallukat, Volker Homuth, Friedrich Luft
  • Quantitative diagnostic analysis of hypertonia
    Publication number: 20060127892
    Abstract: The invention relates to the application of the direct correlation between the overexpression or the functional molecular modification of human homologs of the sgk family and hypertension for quantitative diagnosis of a particular form of genetically determined hypertension. In particular the invention relates to the detection of a direct link between two different polymorphisms of individual nucleotides in the hsgk1 gene and the genetically determined predisposition to hypertension. The invention further relates to the provision of a diagnostic kit containing antibodies or polynucleotides for detecting the diagnostic targets hsgk1, hsgk2 and hsgk3.
    Type: Application
    Filed: March 21, 2002
    Publication date: June 15, 2006
    Inventors: Andreas Busjahn, Friedrich Luft, Florian Lang
  • Use of haplotypes and SNPs in lipid-relevant genes for the analysis and diagnosis of cardiovascular disease
    Publication number: 20050196794
    Abstract: The present invention relates to an in vitro method for diagnosing a genetic predisposition or susceptibility for a cardiovascular disease, condition or disorder in a mammal which comprises detecting of at least three particular single nucleotide polymorphisms (SNP) in a sample obtained from said mammal in at least one of a genomic locus-derived nucleic acid or fragment thereof of the loci APOB, APOE, ABCA1, CETP, LCAT, LIPC, LPL, LDLR, APOC2, APOA5, APOA4, APOC3, and APOA1. Furthermore, the present invention relates to the improved diagnosis that is based on the analysis of several haplotypes for the above-mentioned loci (i.e. a combination of said haplotypes).
    Type: Application
    Filed: February 18, 2005
    Publication date: September 8, 2005
    Inventors: Peter Nurnberg, Jens-Georg Reich, Friedrich Luft, Hans Knoblauch, Anja Bauerfeind, Tatjana Luganskaja, Klaus Rohde
  • Method of treatment for cardiovascular complications
    Patent number: 6486188
    Abstract: The present invention relates to the use of an angiotensin II type 1 receptor antagonist in the manufacture of a medicament for the prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis. The invention further relates to a method for prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis, comprising administering to the patient a therapeutically effective amount of an angiotensin II type 1 receptor antagonist.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: November 26, 2002
    Assignee: AstraZeneca AB
    Inventors: Erling Bjerregaard Pedersen, Friedrich Luft, Anders Svensson, Faies Zannad
  • Hypertonia gene
    Patent number: 6248873
    Abstract: The present invention relates to a hypertonia gene located on chromosome 12p in the genomic region between genome markers AFM338WH5 and D12S1057 and uses of such a gene.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: June 19, 2001
    Assignee: Progen Biotechnik GmbH
    Inventors: Nihat Bilginturan, Sylvia Bähring, Friedrich Luft, Herbert Schuster, Thomas Wienker
  • Non-dispersive infrared gas analysis device with triple layer receiver
    Patent number: 3968369
    Abstract: A radiation receiver including three receiver layers for infrared gas analysis. The first and third layers are connected in parallel, and their pressure is compared with that of the second or middle layer to derive a pressure difference which compensates for certain measurement problems found in prior art devices.
    Type: Grant
    Filed: November 15, 1974
    Date of Patent: July 6, 1976
    Assignee: Bergwerksverband GmbH
    Inventor: Karl Friedrich Luft
  • Non-dispersive infrared gas analyzer
    Patent number: 3968370
    Abstract: An auxiliary signal for the compensation of the difference signal created in optical-pneumatic receivers due to the absorption of radiation, such compensation being achieved by one or more electrical-pneumatic transmitters connected directly to the receiver chambers.
    Type: Grant
    Filed: December 26, 1974
    Date of Patent: July 6, 1976
    Assignee: Bergwerksverband GmbH
    Inventor: Karl Friedrich Luft